Next report date
Report period
Q2 2024
EPS estimate
−0.26USD
Revenue estimate
—
−5.15USD
−99.92 MUSD
7.30 M
About enGene Holdings Inc.
Sector
Industry
CEO
Jason D. Hanson
Website
Headquarters
Saint-Laurent
Employees (FY)
33
Founded
2023
FIGI
BBG01J1GCYW7
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ENGN is 15.89 USD — it has decreased by 0.06% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange enGene Holdings Inc. stocks are traded under the ticker ENGN.
enGene Holdings Inc. is going to release the next earnings report on Jul 3, 2024. Keep track of upcoming events with our Earnings Calendar.
ENGN stock is 5.28% volatile and has beta coefficient of −5.72. Check out the list of the most volatile stocks — is enGene Holdings Inc. there?
Yes, you can track enGene Holdings Inc. financials in yearly and quarterly reports right on TradingView.
ENGN stock has risen by 5.93% compared to the previous week, the month change is a 8.41% fall, over the last year enGene Holdings Inc. has showed a 67.41% decrease.
ENGN net income for the last quarter is −10.71 M USD, while the quarter before that showed −99.84 M USD of net income which accounts for 89.27% change. Track more enGene Holdings Inc. financial stats to get the full picture.
Today enGene Holdings Inc. has the market capitalization of 368.85 M, it has decreased by 3.58% over the last week.
No, ENGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ENGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade enGene Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of May 2, 2024, the company has 33.00 employees. See our rating of the largest employees — is enGene Holdings Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So enGene Holdings Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating enGene Holdings Inc. stock shows the sell signal. See more of enGene Holdings Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on enGene Holdings Inc. future price: according to them, ENGN price has a max estimate of 40.00 USD and a min estimate of 30.00 USD. Read a more detailed enGene Holdings Inc. forecast: see what analysts think of enGene Holdings Inc. and suggest that you do with its stocks.